| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/1999 | US5858743 Delivery of nucleic acids |
| 01/12/1999 | US5858726 Plasmid dna vectors for expression of viral capsid polypeptides and envelope glycoproteins from different virus species; producing self-assembling, non-replicating, non-infectious particles for vaccine and drug therapy |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858413 Contains at least one antacid active substance, sugar or sugar alcohol and water; liquid to semisolid consistency |
| 01/12/1999 | US5858412 Forming aqueous slurry of microcrystalline cellulose and compressibility augmenting agent, drying to form agglomerated particles, adding active agent, incorporating sustained-release carrier |
| 01/12/1999 | US5858406 Blending with electrolyte; eliminates dusting, reduces static charge development when converted to granular, pelletized or tablet form |
| 01/12/1999 | US5858397 Liposomal formulations of mitoxantrone |
| 01/12/1999 | US5858393 Transdermal patch comprising acrylic adhesive, muscarinic agonist; treating alzheimer*s disease, severe pain; reduced side effects |
| 01/12/1999 | US5858382 An oil/water emulsion wherein the oil droplets contain a drug in dissolved or dispersed or solubilized form. |
| 01/12/1999 | US5858380 Stable gelled composition with a high electrolyte content |
| 01/12/1999 | US5858375 Pharmaceutical compositions containing D2 O |
| 01/12/1999 | US5858362 Polysaccharide-protein |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858350 Chitin, chitosan |
| 01/12/1999 | US5858344 Oral administration form having acid active substances and a process for its production |
| 01/12/1999 | US5858330 Comprising active ingredient, colloidal silica, water, excipients |
| 01/12/1999 | CA2164933C Methods for aiding periodontal tissue regeneration |
| 01/12/1999 | CA2104917C Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 01/12/1999 | CA2065809C Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 01/12/1999 | CA1340312C Methods for improved targeting of antibody, antibody fragments, hormonesand other targeting agents and conjugates thereof |
| 01/09/1999 | CA2208924A1 Sparing paclitaxel by the use of hyaluronan |
| 01/07/1999 | WO1999000421A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | WO1999000187A1 Hydrophilic polymeric material and method of preparation |
| 01/07/1999 | WO1999000145A1 Antigenic modulation of viral particules |
| 01/07/1999 | WO1999000141A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 01/07/1999 | WO1999000131A1 Novel process for manufacturing paroxetine solid dispersions |
| 01/07/1999 | WO1999000111A1 Proliposome powders for inhalation stabilised by tocopherol |
| 01/07/1999 | WO1999000015A1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 01/07/1999 | WO1998046270A3 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/07/1999 | WO1998044951A3 Hydrolysable delivery system using cross-linked polymeric resins as vehicles |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998035984A3 Compositions and methods for highly efficient transfection |
| 01/07/1999 | WO1998022141A3 Enhanced effects for hapten conjugated therapeutics |
| 01/07/1999 | EP0889023A1 Process for the preparation of mixtures of sorbitolmonoesters, sorbitoldiesters and partial glycerides |
| 01/07/1999 | EP0888778A1 Colon selective drug delivery system and compositions comprising said system |
| 01/07/1999 | EP0888772A1 Sustained-release metal valproate tablets |
| 01/07/1999 | EP0888771A1 Composition with topical anaesthetic activity |
| 01/07/1999 | EP0888770A1 Compositions comprising cationic polysaccharides and cationic drugs |
| 01/07/1999 | EP0888769A1 Cosmetic compositions containing alkalin alginates lyophilisates |
| 01/07/1999 | EP0888545A1 Super-paramagnetic particles with increased r 1? relaxivity, processes for producing said particles and use thereof |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888384A2 Conjugate for modifying interactions between proteins |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888139A2 Alginate containing antimicrobial composition |
| 01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
| 01/07/1999 | EP0888118A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 01/07/1999 | EP0888117A1 Use of arabinogalactan in a sperm wash product |
| 01/07/1999 | EP0888054A1 Targeted site specific drug delivery compositions and method of use |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0866683A4 Composition and method for treating diseased nails |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | DE19728517A1 TTS zur Verabreichung von Sexualsteroidhormonen TTS for the administration of sex steroids |
| 01/07/1999 | DE19728516A1 TTS zur Verabreichung von Levonorgestrel TTS for the administration of levonorgestrel |
| 01/07/1999 | DE19727978A1 Preparation of medicaments containing sparingly water-soluble metal complexes used to treat cancer |
| 01/07/1999 | CA2765222A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2295028A1 Proliposome powders for inhalation stabilised by tocopherol |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/06/1999 | CN1204345A Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid |
| 01/06/1999 | CN1203787A Ketoprofen slow-releasing tablet and its preparing method |
| 01/05/1999 | US5856571 Semicarbazide-containing linker compounds for formation of stably-linked conjugates and methods related thereto |
| 01/05/1999 | US5856515 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 01/05/1999 | US5856451 Conjugating a polypeptide with a polymer |
| 01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856359 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 01/05/1999 | US5856357 Method for treating wrinkles using certain alpha hydroxyacids |
| 01/05/1999 | US5856355 Pharmaceutical composition |
| 01/05/1999 | US5856345 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
| 01/05/1999 | US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 01/05/1999 | US5856299 Highly reactive esters of carboxy polysaccharides and carboxy polysaccharides derived therefrom |
| 01/05/1999 | US5856271 Mixing active material with dried carrier; heating and casting polyurethane |
| 01/05/1999 | US5856201 Methods of detection using a cellulose binding domain fusion product |
| 01/05/1999 | US5855987 Bioactive conjugates of cellulose with amino compounds |
| 01/05/1999 | US5855916 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin |
| 01/05/1999 | US5855915 Tablets or biologically acceptable implants for long-term antiinflammatory drug release |
| 01/05/1999 | US5855913 Particles incorporating surfactants for pulmonary drug delivery |
| 01/05/1999 | US5855912 Pharmaceutical compositions for piperidinalkanol compounds |
| 01/05/1999 | US5855904 Containing sodium alginate |
| 01/05/1999 | US5855901 Compositions useful for stimulating an immune response to an antigen |
| 01/05/1999 | US5855900 Supramolecular-structured biodegradable polymeric assembly for drug delivery |
| 01/05/1999 | US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present. |
| 01/05/1999 | US5855883 Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II |
| 01/05/1999 | US5855873 Storage stability; mouthwashes |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2175091C Controlled release naproxen tablets |
| 01/05/1999 | CA2152062C Enhanced solubility pharmaceutical solutions |
| 01/05/1999 | CA2132826C Use of borate-polyol complexes in ophthalmic compositions |
| 01/05/1999 | CA2095627C Stable lyophilized fatty emulsions and a process for the production thereof |
| 01/05/1999 | CA2045204C Viral decoy vaccine |
| 01/05/1999 | CA2043366C Dry eye treatment process and solution |
| 01/05/1999 | CA2028931C Hard confections containing hydrogenated isomaltulose and a medicinally active ingredient |
| 12/30/1998 | WO1998059064A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/30/1998 | WO1998058952A1 Angiotensin derivatives |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |